|7337 E. Doubletree Ranch Rd, Suite 100 , Scottsdale, AZ 85258|
|Fund Manager||Team Managed|
The Portfolio seeks long-term capital appreciation. Under normal market conditions, the Portfolio invests primarily inequity securities of issuers located throughout the world that it believes have, among other things, sustainable competitive advantages, capable management and financial strength. The Portfolio may invest in securities of companies of any market capitalization. The sub-adviser (Sub-Adviser) emphasizes individual stock selection and seeks to identify under valued securities of issuers located through out the world, including both developed and emerging market countries. Under normal market conditions, the Portfolio invests in securities of issuers from a number of different countries, including the United States.
|Asset Type||% Of Allocation|
|Total Net Assets||39.41 M|
|Criteria||3 Years||5 Years||10 Years|
|Minimum Initial IRA||$0|
|Timeframe||Average Annual Current Performance Monthly As Of n/a||Average Annual Current Performance Quarterly As Of n/a||Avg Annual Current Performance Monthly As Of n/a||Avg Annual Current Performance Quarterly As Of n/a|
|Life Of Fund||
|Symbol||Company Name||% Of Assets|
|PM||PHILIP MORRIS INTERNATIONAL||8.64%|
|RB.L||RECKITT BENCKISER GROUP||7.24%|
|PG||PROCTER & GAMBLE CO||4.33%|
|TMO||THERMO FISHER SCIENTIFIC INC||4.12%|
Master The Market with the Help of Our Financial Experts
Cloud-software growth stocks have been a bright spot in an uncertain market. Investors might look closely at Cloudflare and Digital Ocean.
Philip Morris posts a third-quarter earnings beat as sales of its smokeless non-tobacco products continue strong, though cautions on supply chain impact.
Travelers Companies posts third-quarter earnings that exceed analysts’ forecasts as a drop in what it calls ‘catastrophic losses’ offsets record net written premiums.
Solid third quarters continue to power stocks higher Tuesday, even as growth and inflation signals remain stubbornly persistent as oil prices top $85 a barrel in overnight trading.
Procter & Gamble held its 2022 forecasts in place, seeing sales growth of between 2% and 4%, following stronger-than-expected first quarter earnings.
Johnson & Johnson said it sees 2021 vaccine sales of $2.5 billion, with overall revenues rising to between $94.1 billion to $94.6 billion, following its Q3 earnings beat.
Stocks edge higher ahead of earnings; SEC says GameStop surge powered by believers; FDA set to approve "mix & match' COVID boosters; DraftKings faces Entain bid deadline and Rent the Runway seeks $1.3 billion valuation in Nasdaq IPO.